SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (336)11/5/2002 8:45:43 AM
From: quidditch  Read Replies (1) of 508
 
Thanks, IJ,

What is the date of the CHEST meeting, at which further analysis of the recently completed P3 study (as well as additional weeks of actimmune vs. placebo on an unblinded basis) may be discussed? Is this Philadelphia?

Thanks,

quid

PS Can always tell an early AM ITMN release will be under your moniker. By the way, what is a "prospective" randomized PIV clinical trial?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News